MiR-125b-5p/STAT3 Axis Regulates Drug Resistance in Osteosarcoma Cells by Acting on ABC Transporters

Yang Yang1, Yueyuan Chen2, Jiajia Liu1

  • 1Department of Trauma Center, Affiliated Hospital of Nantong University, Nantong City, Jiangsu Province 226001, China.

Abstract

Insights

MicroRNA-125b-5p enhances osteosarcoma drug sensitivity by inhibiting the STAT3 pathway, which regulates ABC transporters. This finding offers new therapeutic strategies for drug-resistant osteosarcoma.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Osteosarcoma exhibits poor prognosis due to drug resistance.
  • Understanding resistance mechanisms is crucial for developing effective treatments.
  • The role of miR-125b-5p in osteosarcoma drug resistance remains unclear.

Purpose of the Study:

  • To investigate the effects of miR-125b-5p on drug resistance in osteosarcoma cells.
  • To elucidate the molecular mechanisms underlying miR-125b-5p's role in osteosarcoma.
  • To identify potential therapeutic targets for overcoming drug resistance.

Main Methods:

  • Osteosarcoma-resistant miR-125b-5p was identified using bioinformatics databases.
  • Cell proliferation, migration, invasion, and apoptosis were assessed using CCK8, western blot, and transwell assays.
  • Bioinformatic analysis and binding site validation were employed to identify targeting factors and pathways.

Main Results:

  • Upregulation of miR-125b-5p inhibited osteosarcoma cell proliferation, migration, and invasion while promoting apoptosis.
  • miR-125b-5p was found to restore drug sensitivity in drug-resistant osteosarcoma cells.
  • miR-125b-5p targets the 3'-UTR of signal transducer and activator of transcription 3 (STAT3), inhibiting its expression.

Conclusions:

  • The miR-125b-5p/STAT3 axis plays a critical role in mediating osteosarcoma drug resistance.
  • STAT3 influences drug resistance in osteosarcoma by regulating ABC transporters.
  • Targeting the miR-125b-5p/STAT3 pathway presents a promising strategy for treating drug-resistant osteosarcoma.

Related Concept Videos

ABC Transporters: Exporter01:31

ABC Transporters: Exporter

ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
4.4K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
ABC Transporters: Importer01:27

ABC Transporters: Importer

ATP-binding cassette or ABC transporters are a class of ATP-driven pumps that hydrolyze ATP to move solutes across the membrane. They can be grouped into importers and exporters. While exporters are present in all domains of life, importers exist only in bacteria and some plants.
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:
2.8K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
2.8K